A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
Clinical trial NCT07058545 · COMPLETED
Trial details
- NCT number
- NCT07058545
- Sponsor
- Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2023-02-20
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.